Mass drug administration of ivermectin and dihydroartemisinin-piperaquine as an additional intervention for malaria elimination (MASSIV)
Contact: Umberto d'Alessandro
Funded by: MRC

Will the ongoing use of a two-dose, rather than three-dose schedule of pneumococcal conjugate vaccine, have similar impact in rural Gambia? (PVS - JGHT)
Contact: Grant McKenzie
Funded by: MRC

A cluster-randomized non-inferiority trial of the effect of a two compared to three dose schedule of pneumococcal conjugate vaccine (PVS-BMGF)
Contact: Grant McKenzie
Funded by: BMGF

Population based approach to malaria research and control (ICEMR)
Contact: Davis Nwakanma
Funded by: NIH

Gambia Hepatis Intervention Study (IARC)
Contact: Ramou Njai
Funded by: WHO

Surveillance of invasive Haemophilus influenzae type b (Hib) infection in the Western Region of The Gambia
Contact: Akram Zaman
Funded by: GAVI

The Rotavirus vaccine effectiveness study (VIDA)
Contact: Jahangir Hosain
Funded by: BMGF

Can improved housing provide additional protection against clinical malaria over current best practice? A household-randomised controlled trial
Contact: Margaret Pinder
Funded by: MRC

Monitoring insecticide resistance in The Gambia
Contact: Umberto D'Alessandro
Funded by: Global Fund

Randomised controlled trial of early kangaroo mother care for hospitalised neonates <2000g (eKMC- Helen Brotherton's Fellowship)
Contact: Helen Brotherton
Funded by: Wellcome Trust

Developing excellence in leadership, training and science (DELTAS) Africa Award: ‘WACCBIP-WELLCOME TRUST DELTAS PROGRAMME’
Contact: Alfred Ngwa
Funded by: Wellcome Trust

Real time malaria surveillance data capture using Mobile data collection service (MDCS)
Contact: Umberto D'Alessandro
Funded by: Global Fund

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union (PERFORM)
Contact: Efua Yussuf
Funded by: EU

Optimizing a deployable high efficacy malaria vaccine (OptiMalVax)
Contact: Umberto D'Alessandro
Funded by: EU

Developing Excellence in Leadership and Genetic Training for Malaria Elimination in Sub-Saharan Africa (DELGEME DELTAS- Mali)
Contact: Alfred Ngwa
Funded by: Wellcome Trust

Maximising the public health impact of interventions to control malaria in pregnancy through the translation of EDCTP-funded evidence-based global policies to country level policies and plans (IMPPACT)
Contact: Umberto d'Alessandro
Funded by: EDCTP

Towards the end game: operational research on improving rural housing in sub-Saharan Africa as a strategy to support malaria elimination
Contact: Margaret Pinder
Funded by: Durham University

The relationship between malarial anaemia, neutrophil function and susceptibility to invasive bacterial disease (AMAN)
Contact: Umberto d'Alessandro
Funded by: MRC

MalariSense 2016
Contact: Umberto d'Alessandro
Funded by: NIH

A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria (CKAF)
Contact: Umberto D'Alessandro
Funded by: Quintiles

Malaria Research Capacity Development in West and Central Africa (MARCAD DELTAS Senegal)
Contact: Umberto d'Alessandro
Funded by: Wellcome Trust

The PROLIFICA screen and treat intervention programme in The Gambia, West Africa: a second phase of liver assessment
Contact: Maud Lemoine
Funded by: Gilead

Reactive household self-administered treatment against residual malaria tranmission (RHOST)
Contact: Umberto D'Alessandro
Funded by: MRC

Evaluation of 10-13 Valent pnuemococcal conjugate vaccine in The Gambia: A Phase IV effectiveness Study (PSP)
Contact: Grant McKenzie
Funded by: BMGF

PSP 2017- A study to determine the impact of PCV13 on pneumocoocal carriage and to prepare for a trial of alternative PCV scheduling in The Gambia
Contact: Grant McKenzie
Funded by: BMGF

PSP 2017- Extension of a study to measure the full impact of PCV13 on invasive pneumococcal disease and radiologic pneumonia in The Gambia
Contact: Grant McKenzie
Funded by: Pfizer

Plasmodium falciparum drug resistance in The Gambia: identification of potential markers by retrospective genomics approaches (CDA Award)
Contact: Alfred Ngwa
Funded by: MRC

Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase III double-blind randomized (Pregnanzi II)
Contact: Anna Roca
Funded by: MRC

Rheumatic Heart Disease
Contact: Annette Erhart
Funded by: Wellcome Trust

Feasibility of the Nanobubble Technology for Detection of Malaria” (Malarisense 2)
Contact: Umberto D'Alessandro
Funded by: Masimo Corp

Genetic interactions between human populations and malaria parasites in different environmental settings across Africa
Contact: Alfred Ngwa
Funded by: AESA

Immunogenicity of intranasal live attenuated influenza vaccination (LAIV) and bidirectional interactions with the host microbiome
Contact: Thushan de Silva
Funded by: Wellcome Trust

PERtussIS COrrelates of Protection Europe
Contact: Beate Kampmann
Funded by: EU

Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
Contact: Beate Kampmann
Funded by: NIH

Validation of Biomarkers of Paediatric TB and further development for use in diagnosis
Contact: Beate Kampmann
Funded by: NIH

Audio-visual tool to train primary Health workers to strengthen the expanded Program on Immunization in the Gambia
Contact: Beate Kampmann
Funded by: Bull City Learning, Inc

Research Agreement between Micron and MRC 
ContactEd Clarke
Funded by: BMGF

GAIA Extension : Global Alignment of Immunization safety assessment in pregnancy
Contact: Ed Clarke
Funded by: BMGF

Center for Research on the Respiratory Microbiota of African Children (ReMAC)
Contact: Martin Antonio
Funded by: NIH

Surveillance for Vaccine Preventable Invasion Bacterial Diseases
Contact: Martin Antonio
Funded by: WHO

Pathogenesis and risk factors of long-term sequelae of pulmonary TB defining individual outcomes and public health impact”
Contact: Beate Kampmann
Funded by: EU

Maternal Immunisation in West Africa
Contact: Beate Kampmann
Funded by: Pfizer

Improving the Diagnostics of Childhood Tuberculosis in High Burden Settings
Contact: Beate Kampmann
Funded by: Grand Challenge Canada

Screen TB
Contact: Jayne Sutherland
Funded by: EDCTP

Molecular Diagnostics for Diarrhea Etiology and Vaccine Efficacy in the Rotavirus Vaccine Impact Study
Contact: Martin Antonio
Funded by: BMGF

Evaluation of alternative immunization schedule to prevent pneumococcal carriage/disease in early infancy
Contact: Ed Clarke
Funded by: MRC

Childhood Tuberculosis: Integrating tools for improved diagnosis and vaccines
Contact: Beate Kampmann
Funded by: MRC

Maternal Vaccination with MenAfriVac
Contact: Ed Clarke
Funded by: MRF

Vaccine Development for poverty related and negtected Infectious diseases: Tuberculosis
Contact: Jayne Sutherland
Funded by: EU

A randomised, observer blind, non-inferiority trial to evaluate alternative human papillomavirus (HPV) vaccination schedules in young females in The Gambia
Contact: Ed Clarke
Funded by: MRC

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, Lot-to-Lot Consistency, Immunogenicity, and Non-Interference with Concomitant Vaccinations of Serum Institute of India’s 10-Valent Pneumococcal Conjugate Vaccine (PNEUMOSIL®) in Healthy Infants in The Gambia
Contact: Ed Clarke
Funded by: PATH

Evaluating novel diagnostics and enbaling preventive measures for childhood tuberculosis between the UK and partners in Sub-Saharan Africa
Contact: Beate Kampmann
Funded by: EU

Pump Primping - The Nutrition-infection axis in the aetiology of diabetes in Africa and Asia
Contact: Sarah/Sophie Moore
Funded by: GCRF

Evaluation of MTHFR C677T genotype-dependent blood pressure response
Contact: Branwen Hennig
Funded by: APCDR

Developing reference values of human milk micronutrient (MN) composition
Contact: Sophie Moore
Funded by: BMGF

Creating a West African BioResource for Nutritional Genetics and Epigenetics
Contact: Andrew Prentice
Funded by: MRC

Identification of nutritionally modifiable homonal epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants (HERO-G)
Contact: Sophie Moore
Funded by: BMGF

Impact of maternal diet on the epigenome and potentially modifiable effects on offspring health (new diet and epigenetics grant (MDEG2)
Contact: Matt Silver
Funded by: MRC

Epigenetic mechanisms linking maternal pre-conceptional micronutrient supplementation with offspring health in India and The Gambia (Newton Grant, Emphasis) 
Contact: Andrew Prentice
Funded by: MRC

Recruit 200 West Kiang infants, prospectively from pregnancy to 2 years of age to create ‘brain function-for-age’ curves, and relate these to physical growth, behavioural assessments and socio-economic status (fNIRS)
Contact: Claire Elwell
Funded by: BMGF

Gambia - ING - IHAT (Gates) - A novel nano-iron supplement (IHAT) to safely combat iron deficiency and anaemia (IDA)
Contact: Dora Perreira
Funded by: BMGF

Neonatal iron metabolism and risk of infection
Contact: Andrew Prentice
Funded by: BMGF

Coast 2 Coast Ethics
Contact: Jonas Lexow
Funded by: EDCTP